Catalent Inc
NYSE:CTLT
Catalent Inc
NYSE:CTLT
Price:
55.37 USD
0.2%
Market Closed
Updated:
May 19, 2024
Catalent Inc
Total Equity
|
Catalent Inc
Total Equity Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Catalent Inc
NYSE:CTLT
|
Total Equity
$3.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Equity
$70B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-1%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Equity
$16.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Equity
$92.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Equity
$40.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Equity
$12.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
39%
|
CAGR 10-Years
-4%
|
See Also
What is Catalent Inc's Total Equity?
Total Equity
3.6B
USD
3.6B
USD
Based on the financial report for Mar 31, 2024, Catalent Inc's Total Equity amounts to 3.6B USD.
What is Catalent Inc's Total Equity growth rate?
Total Equity CAGR 5Y
17%
17%
Over the last year, the Total Equity growth was -23%. The average annual Total Equity growth rates for Catalent Inc have been -4% over the past three years , 17% over the past five years .
You don't have any saved screeners yet
